When most people picture the opioid crisis, they picture a young adult. The reality is more complicated — and more troubling. Opioid use disorder in elderly patients is one of the fastest-growing and least-discussed corners of the opioid epidemic, quietly accelerating behind the statistics we hear most often.
Among Medicare beneficiaries aged 65 and older, OUD rates nearly tripled in just five years — rising from 4.6 to 15.7 cases per 1,000 beneficiaries between 2013 and 2018. Opioid overdose deaths in the same age group climbed 53% from 2013 to 2020. Close to one million Americans over the age of 65 now live with opioid use disorder, and most of them developed it through a legally written prescription.
This is not a niche problem. For pain management providers across Virginia, Maryland, and Delaware, it is a patient population that demands a more careful, more informed approach.
How Common Is Opioid Use Disorder in the Elderly?
The numbers are starker than most people realize. A 2021 study analyzing Medicare data found that OUD among adults 65 and older more than tripled between 2013 and 2018. Approximately 30% of the 50,000 Medicare enrollees who died from OUD between 2013 and 2016 were aged 60 or older.
Yet MOUD (medication for opioid use disorder) use among this population remains critically low. Only 4.8% of elderly Medicare patients with diagnosed OUD received MOUD in 2017. By 2022, that number had risen to 15% — progress, largely driven by a new Medicare payment policy covering methadone for OUD treatment. But 85% still go untreated.
That gap reflects a system-wide failure — one rooted in physiology, stigma, clinical blind spots, and a long history of overlooking seniors in addiction medicine.
For context on how prescribing practices contributed to this problem, the 2022 CDC opioid prescribing guidelines offer important background on what changed and why.
Why Opioids Are Especially Dangerous for Seniors
Opioids carry risks at any age. In older adults, those risks compound in ways that are physiologically predictable — and often underestimated by prescribers.
1. Slowed Metabolism and Drug Accumulation
Aging dramatically changes how the body processes opioids. Kidney and liver function decline over time, slowing the clearance of opioid metabolites. Body fat increases while lean muscle mass decreases, altering how drugs distribute through tissue. The result: opioids stay active in an elderly patient’s system far longer than in a younger adult receiving the same dose.
This means a dose that is therapeutic on day one can become toxic by day seven. Accumulation increases the risk of respiratory depression — the mechanism behind most opioid overdose deaths — without the dose ever formally being “too high.”
2. Fall Risk and Cognitive Impairment
Opioid use disorder in elderly patients significantly elevates the risk of falls. Opioids cause sedation, dizziness, and slowed reaction time — all of which are more dangerous in older adults who may already have balance deficits or osteoporosis.
A fall that would leave a younger person bruised can leave an elderly person with a hip fracture, hospitalization, and a cascade of complications. Opioids also contribute to delirium and cognitive decline in seniors, symptoms that are frequently misattributed to aging or dementia rather than to medication effects.
This physiological vulnerability is part of what makes long-term opioid use so concerning in this population. Understanding opioid-induced hyperalgesia — where prolonged use actually increases pain sensitivity — is equally important context for any senior managing chronic pain with opioids.
The Polypharmacy Problem: When Opioids Collide With Other Drugs
The average older adult takes five or more prescription medications. This reality makes opioid use disorder in elderly patients a polypharmacy emergency as much as an addiction issue.
Research on Medicare patients with diagnosed OUD found that 38% were also receiving benzodiazepine prescriptions. The combination of opioids and benzodiazepines is one of the deadliest drug interactions in medicine — both suppress the central nervous system, and together they dramatically increase the risk of fatal respiratory depression.
Beyond benzodiazepines, seniors with OUD frequently take medications for hypertension, diabetes, heart failure, and COPD. Many of these interact with opioids or intensify their sedating effects. Anticoagulants, antihypertensives, and certain antidepressants all carry compounded risk when opioids are added to the mix.
Managing opioid use disorder in older adults therefore requires reviewing the entire medication list — not just the opioid. This is a complexity that general practitioners may not be equipped to navigate without specialist support.
Why Opioid Use Disorder in Elderly Patients Goes Undiagnosed
Underdiagnosis is one of the defining features of this crisis. Opioid use disorder in elderly patients presents differently than it does in younger populations, and clinicians often miss it.
Younger patients may show clear behavioral changes, social deterioration, or problems at work. In seniors, the same disorder may look like fatigue, increased confusion, appetite loss, or withdrawal from social activities — all of which are easily dismissed as normal aging or attributed to other comorbidities.
Provider bias plays a role too. Ageism in clinical settings means some practitioners are slower to screen seniors for addiction, operating on an unconscious assumption that the problem belongs to younger demographics. Seniors are also less likely to volunteer concerns about their opioid use, shaped by generational beliefs that associate addiction with moral failure rather than medical condition.
Underreporting means the true prevalence of OUD in this population is almost certainly higher than the data reflects. Addressing this requires better screening tools calibrated for older adults, not just younger patients.
Health disparities compound the picture further. Racial and socioeconomic gaps in pain treatment mean that elderly patients from minority communities are even less likely to receive adequate diagnosis or care.
Geriatric Pain Management: Safer Paths Forward
Opioid use disorder in elderly patients often begins with undertreated chronic pain. Arthritis, spinal degeneration, neuropathy, and post-surgical pain are all common in this age group — and opioids have historically been the default solution.
That default is increasingly questioned. The 2022 CDC opioid prescribing guidelines strongly recommend non-opioid and non-pharmacologic therapies as first-line treatment for both acute and chronic pain, with opioids reserved for cases where benefits clearly outweigh risks.
For older adults with complex pain conditions, interventional approaches often outperform opioids while carrying a far safer risk profile. These include nerve blocks, radiofrequency ablation, epidural steroid injections, and intrathecal drug delivery (pain pump therapy) — all of which deliver targeted relief without the systemic exposure that makes oral opioids so dangerous in seniors.
For more on non-opioid approaches, see options for patients looking to stay away from pain medication.
Geriatric pain management done well addresses the full picture: the underlying pain generator, the patient’s comorbidities, their medication list, and their functional goals. Opioids, when necessary, should be the last tool selected — not the first.
Treating Opioid Use Disorder in Older Adults: MOUD Options
When opioid use disorder in elderly patients is diagnosed, medication for opioid use disorder (MOUD) is the evidence-based standard of care. Both buprenorphine and methadone have been shown to significantly reduce mortality risk in patients with OUD. But not all MOUD options carry equal risk in older adults.
Buprenorphine: The Preferred First Choice
Buprenorphine is generally considered the safest MOUD option for elderly patients. It has fewer dangerous drug-drug interactions than methadone and does not carry the same risk of cardiac arrhythmia (specifically QTc prolongation). The “start low, go slow” dosing principle applies — older adults typically require lower starting doses and more gradual titration.
Buprenorphine is now accessible via telehealth in most states, removing the transportation barriers that have historically kept seniors from accessing treatment. This is a significant development for older adults with mobility limitations or those in rural areas.
A 2025 narrative review of OUD in older adults, published in Current Geriatrics Reports, confirms that while buprenorphine and methadone both reduce mortality risk substantially, optimal dosing and delivery models for older adults remain underexplored — making individualized clinical evaluation essential.
Naltrexone: A Viable Alternative
Naltrexone, an opioid antagonist, carries fewer drug interactions and no abuse potential — making it an attractive option for older patients who have already completed detoxification. It is available as an extended-release monthly injection (Vivitrol), which removes the daily medication adherence burden.
The limitation: naltrexone requires full opioid detoxification before initiation. For elderly patients with complex pain conditions, managing that detox process requires careful clinical oversight.
Methadone: Greater Caution Required
Methadone is effective for OUD, but its risk profile in older adults demands heightened vigilance. QTc prolongation — an abnormality in heart rhythm — is a well-documented risk, particularly dangerous in elderly patients who may already have cardiac conditions. Drug interactions are numerous, and methadone’s long half-life makes dosing errors especially consequential in a population with impaired drug clearance.
A review of MOUD safety in elderly patients found that buprenorphine and naltrexone have fewer potentially lethal adverse effects compared to methadone for treating opioid use disorder in older adults. When methadone is used, more frequent monitoring and careful cardiac evaluation are essential.
The Family and Caregiver Role in Senior OUD Recovery
Families and caregivers are often the first to notice that something has changed — and often the last to connect it to opioid use disorder in elderly patients.
Warning signs worth watching for include increased confusion or sedation between doses, requests for early refills, unusual drowsiness, withdrawal from activities the senior previously enjoyed, or mood changes that seem out of character. Medication hoarding and secretive behavior around pills are also red flags.
Having the conversation about OUD with an elderly loved one is difficult. Generational stigma is real — many seniors associate addiction with personal failure, not with medical vulnerability. Framing it as a medication response, not a character issue, is more likely to open a dialogue than a confrontation.
Caregivers can also play a concrete role in medication management: organizing pill dispensers, attending medical appointments, requesting a full medication review from the patient’s physician, and asking directly about opioid monitoring protocols. These practical steps reduce the risk of polypharmacy and catch problems before they escalate.
If opioid use disorder is suspected, connecting the patient to a pain management specialist — rather than relying solely on a primary care provider — ensures access to the full range of MOUD options and interventional alternatives. Pain pump therapy, explored in our article on opioid addiction and pain pump treatment, is one such option for patients with co-occurring chronic pain and opioid dependence.
Conclusion
Opioid use disorder in elderly patients is not a marginal concern. It is a growing, underdiagnosed, and undertreated crisis hiding in plain sight — in Medicare data, in nursing home charts, and in the homes of families who don’t yet have the language to name what they’re seeing.
The risks are real. The biology is unforgiving. But so are the treatment options — effective, evidence-based, and increasingly accessible. No patient is too old to benefit from proper diagnosis and care.
If you or a loved one is an older adult managing chronic pain with opioids, or if you suspect opioid use disorder may be a factor in declining function, the team at Advanced Spine and Pain can help. Our providers serve patients across Virginia, Maryland, and Delaware with comprehensive pain management and individualized treatment planning.
